MetaCap

MaxCyte Inc. Company Profile

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.37+0.09 (+7.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MaxCyte at a glance

MaxCyte Inc. (NASDAQ: MXCT) is a Biotechnology: Commercial Physical & Biological Resarch company in the Health Care sector headquartered in Rockville, MD. MaxCyte is led by Mr. Maher Masoud and employs about 91 people. The company's shares have traded publicly since 2021.

At a market capitalization of $141.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001287098, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does MaxCyte do?

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Business description based on the company's public filings.

Company information

Legal name
MaxCyte Inc.
Ticker
NASDAQ: MXCT
Industry
Biotechnology: Commercial Physical & Biological Resarch
CEO
Mr. Maher Masoud
Employees
91
Headquarters
9713 Key West Avenue, Rockville, MD, United States
Phone
301 944 1700
IPO year
2021
Market cap
$141.45M
SEC CIK
0001287098
Latest annual report
10-K · Mar 25, 2026

Companies similar to MaxCyte

MXCT peer companies
CompanyPrice% ChgMarket capCompare
ONMDOneMedNet Corp Class A4.70+4.21%$29.15Mvs MXCT
BIAFbioAffinity Technologies Inc.1.65-10.81%$3.00Mvs MXCT
ISPCiSpecimen Inc.0.4563-13.58%$2.64Mvs MXCT
NRCNRC Health25.16+0.68%$533.93Mvs MXCT
OABIOmniAb Inc.4.66-7.36%$679.71Mvs MXCT
ABSIAbsci Corporation7.51-7.97%$1.30Bvs MXCT
ICLRICON plc186.71-1.92%$13.99Bvs MXCT
CRLCharles River Laboratories International Inc.314.32-4.15%$15.06Bvs MXCT

Related